AbCellera Biologics Inc. ABCL Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s operating lease ROU assets?
- AbCellera Biologics Inc. (ABCL) reported operating lease ROU assets of $134.3M in Q1 2026.
- How has AbCellera Biologics Inc.'s operating lease ROU assets changed year-over-year?
- AbCellera Biologics Inc.'s operating lease ROU assets increased by 95.4% year-over-year, from $68.74M to $134.3M.
- What is the long-term trend for AbCellera Biologics Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s operating lease ROU assets has grown at a 36.4% compound annual growth rate (CAGR), from $73.14M to $136.12M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.